You just read:

Auxilium Pharmaceuticals, Inc. and Xstelos Holdings, Inc. Receive 505(b)(2) Paragraph IV Certification Notice from Upsher-Smith Laboratories, Inc. for Testim®

News provided by

Auxilium Pharmaceuticals, Inc.

Jan 03, 2013, 07:00 ET